| 1888 Press Release | Medical News | Pharmaceuticals News | Pharmaceuticals RSS |  |
Latest Pharmaceuticals News & Press Releases |
||
|
New Video Reveals Psychiatric Drugging Industry
Documentary Video depicts the field of psychiatry as a money-grubbing industry dedicated to making a profit at the expense of the mental health of their own patients. By Citizens Commission On Human Rights - November 08, 2009 |
|
Monoclonal Antibodies to Drive Protein Therapeutics Market
Global protein therapeutics market is forecast to grow at a CAGR of around 15% in next three years, says RNCOS in its report. By Rncos - November 07, 2009 |
|
Healthcare Reform to Accelerate Chinese Pharma Market
Pharmaceutical market in China is projected to grow at a CAGR of over 18% during 2010-2012, driven by increasing prevalence of diseases and increasing penetration of health insurance. By Rncos - November 04, 2009 |
|
ABC Translation Services Announces a New Life Sciences Division
No other field demands as much linguistic and subject matter expertise to responsibly translate with precision and care. The need for highly specialized and accurate translations for the pharmaceutical, medical, health, and bio-tech communities has increased, and requires special expertise. To meet this need, ABC Translations has developed a special Life Sciences Translation Division. By Abc Translation Services - November 02, 2009 |
|
CSC Pharmaceuticals, Mumbai announces the launch of their Business Website
CSC Pharmaceuticals, Mumbai is delighted to announce the launch of its totally redesigned website www.cscmediworld.com that will be of tremendous value to our customers. By Csc Pharmaceuticals, Mumbai - November 01, 2009 |
|
O'Hara Technologies Inc. Introduces Multi-Purpose Lab Coating System – Labcoat M/MX 3-in-1
O’Hara Technologies, the cost effective coating solutions provider in North America introduced a new multi functional laboratory coating system branded Labcoat MX 3-in-1. By Ohara Technologies - October 30, 2009 |
|
MedPro Rx, Inc. Releases Podcast On Von Willebrand Disease
Jeff Harper Provides Information On Most Common Inherited Bleeding Disorder. By Mmi Public Relations - October 30, 2009 |
|
Curaxys, The New Spanish Biopharmaceutical Company Pioneer On Biopharmaceuticals Biosimilars
Curaxys is the new company specialized in the production of biosimilars medicines. It is an independent private company, located on the technological park of Cadiz Spain). The new venture is focuses in the development of new technological platforms. By Curaxys - October 27, 2009 |
|
Granules Posts Record Revenue, Net Profit Increases 121%
Revenue of 96.44 Cr Highest revenue achieved in a quarter by the company Net profit of Rs 7.75 Cr.Consolidated turnover at Rs 114.55 Cr. By Hanmer Ms And L - October 27, 2009 |
|
South Africa Pharma to Post Strong Growth in Future
Pharma market in South Africa is forecasted to grow at a CAGR of more than 8% in next three years, says a new research report by RNCOS. By Rncos - October 24, 2009 |
|
Fluid Transfer Options to be AdvantaPure(R)'s Emphasis at the ISPE Annual Meeting
Tubing and hose choices for liquid transfer in pharmaceutical manufacturing processes will be the focus of AdvantaPure’s table at this year’s ISPE Meeting. Single use systems, identification solutions, and molded components will also be highlighted. By Newage Industries/advantapure - October 22, 2009 |
|
MedPro Rx Client Discusses Benefits Of IVIg Therapy In New Podcast
Treatment From Local Specialty Pharmacy Helps Catherine Russo Fight Lambert-Eaton Myasthenic Syndrome. By Mmi Public Relations - October 17, 2009 |
|
Christopher Dowd Named Executive Vice President, Business Development, of Publicis Strategic Solutions Group
Publicis Strategic Solutions Group — a provider of multichannel message delivery solutions for the life sciences industry — announced Christopher Dowd was named EVP, Business Development. He is responsible for leading the business development activities of Publicis Strategic Solutions Group (a div of Publicis Healthcare Communications Group), which aligns Publicis’ key message delivery companies. By Publicis Strategic Solutions Group - October 14, 2009 |
|
Florida Independent Pharmacies Present Health Care Concerns To U.s. Senator Bill Nelson
U.S. Senator Bill Nelson's office continues the debate on health care reform with Florida independent pharmacies represented by the Good Neighbor Pharmacy group which represents over 3000 independent pharmacies nationwide. Concerns discussed: mail ordering, accreditation, new legislation costs, large chain partnerships, oxygen therapy coverage, and the substantial role of independents pharmacies. By Dkmc, Inc. - October 10, 2009 |
|
MedPro Rx, Inc. Named To Triangle Business Journal’s Top Women-Owned Businesses List
Local Specialty Infusion Pharmacy Named One Of The Triangle’s Top Women-Owned Businesses. By Mmi Public Relations - September 30, 2009 |
|
AdvantaPure(R) to Highlight Product Innovations at Upcoming BioProcess International(TM) Exhibition
Silicone tubing and manifold manufacturer AdvantaPure will exhibit its latest high purity product developments at the upcoming trade show to be held October 12-16, 2009, in Raleigh, NC. The company offers products for single use biopharmaceutical process systems that include tubing sets, molded silicone manifolds and container closures, and DocuLink(TM), a new manifold identification system. By Newage Industries/advantapure - September 29, 2009 |
|
Terra - XRD analyzer for counterfeit pharmaceuticals identification
inXitu's recent advances in the field of X-ray diffraction now make it possible to introduce XRD analysis as a portable inspection tool for the purpose of phase identification and quantification of counterfeit pharmaceuticals. By Inxitu - September 25, 2009 |
|
South Africa to Lead Pharmaceutical Market in Middle East and Africa
Pharma market in South Africa is forecasted to grow at a CAGR of over 8%, mainly driven by increasing prevalence of lifestyle-related diseases and high investments in R&D sector. By Rncos - September 25, 2009 |
|
MedPro Rx, Inc. Named Local Presenting Sponsor For North Carolina Hemophilia Walk
Specialized Pharmacy Supports Fundraising Event Dedicated To Bleeding Disorder Research. By Mmi Public Relations - September 23, 2009 |
|
Rapid Drug Detection celebrates the completion of 3 years in online drug tests business
Rapid Drug Detection completed 3 years in online drug tests selling business. Over the years, Rapid Drug Detection won the trust of thousands of customers across the country by serving them with products of unmatched quality, approved by FDA & that conform to SAMHSA-recommended cutoff levels. By Rapid Drug Detection - September 17, 2009 |
|
L2D Services launches its new non-clinical development solutions at BioPartnering Europe
Paris (France), 15 September 2009 – The launch of L2D Services, the first independent company of its kind specialising in the management of the non-clinical development of therapeutics, was announced today. L2D (Leads to Development) Services, which is based in Paris, will attend the BioPartnering Europe event to be held in London from 11 to 13 October 2009. By Mission Economique Ubifrance Londres - September 17, 2009 |
|
Novartis investigational bronchodilator QAB149 improves lung function and reduces breathlessness compared to tiotropium in patients with COPD
Novartis announced today results from Phase III trials showing QAB149 (indacaterol), an investigational once-daily bronchodilator for chronic obstructive pulmonary disease (COPD), significantly improves lung function and provides a significant reduction in breathlessness compared to tiotropium, a current treatment option. By Economic News - September 16, 2009 |
|
Nutraceuticals market in India showing tremendous growth potential, finds Netscribes' report
Netscribes (India) Pvt. Ltd., launches Nutraceuticals Market – India report covering the Indian Nutraceutical Industry. The report is part of Netscribes’ healthcare industry series. By Netscribes - September 15, 2009 |
|
PenCol Compounding Pharmacy Has Solution for Armour® Thyroid Backorder
Millions of Americans requiring the scarce thyroid medication, Armour Thyroid, now have a solution. By Pencol Compounding Pharmacy - September 15, 2009 |
|
Richard Lev Named Chief Compliance Officer of Publicis Strategic Solutions Group
Publicis Strategic Solutions Group—a provider of multichannel message delivery solutions for the life sciences industry—says Richard S. Lev, JD, named Chief Compliance Officer. Lev will oversee the Corporate Compliance Program to review & evaluate compliance issues/concerns within the organization. By Publicis Strategic Solutions Group - September 10, 2009 |
|
Novartis MF59® adjuvanted cell culture-based vaccine shows strong immune response in A(H1N1) clinical trials
A pilot trial of Novartis adjuvanted cell culture-based A(H1N1) vaccine[1] indicates that the "swine flu" vaccine elicited a strong immune response and was well tolerated. The trial was run by the UK's University of Leicester and University Hospitals of Leicester. The vaccine, to be called Celtura®, was tested with 100 healthy volunteers, aged between 18 and 50. By Financial News - September 05, 2009 |
|
Novartis hosts scientific symposium in Philippines to review research approaches, clinical management, and growing presence of Dengue
The Novartis Institute for Tropical Diseases (NITD) is hosting a global symposium in the Philippines, bringing world-renowned Dengue experts together to discuss critical issues facing Dengue treatment and prevention. By Economic News - September 02, 2009 |
|
Veeda UK Awarded The MHRA Phase I Supplementary Accreditation
Veeda UK today announced that it is been awarded Supplementary accreditation for conducting clinical pharmacology Phase I Trials in Europe by the Medicines and Healthcare products Regulatory Agency (MHRA). By Veeda Clinical Research - August 28, 2009 |
|
ClinPharm Consulting Forms Strategic Partnership with Leading Pharmacokineticist
Bill Wargin, Ph.D. to provide key PK/PD services to drug development consulting firm. By Menzies Consulting - August 27, 2009 |
|
US FDA approves Extavia® - the first in a new portfolio of planned MS therapies from Novartis to help patients with this devastating disease
The US Food and Drug Administration (FDA) has approved Extavia® (interferon beta-1b), the first in a new planned portfolio of multiple sclerosis (MS) medicines from Novartis to help patients manage this devastating disease. By Business Updates - August 19, 2009 |
| 1 2 3 4 5 6 7 8 9 10 11 12 13 14 Next Last Page |
| Search |
| Search Press Release: |
| Bookmark Pharmaceuticals RSS |
|
|
